Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Dec-23 4:29 PM View:  | Chudnovsky Yekaterina Director 10% Owner | Elicio Therapeutics, Inc. (ELTX) | 22-Dec-23 | Purchase | 1,213,000 | $5.81 | $7,047,530.00 | 173% 702.64K to 1.92M | |
| 11-Jul-22 7:54 PM View: | Goldberg Itzhak Director | Elicio Therapeutics, Inc. (ELTX) | 01-Jul-22 | Payment of Exercise | 32,082 | $1.12 | $35,931.80 | (2%) 1.72M to 1.69M | |
| 27-May-22 4:18 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 25-May-22 | Private Purchase | 11,313 | $1.25 | $14,102.80 | < 1% 1.88M to 1.89M | |
| 25-May-22 5:58 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 24-May-22 | Purchase | 32,200 | $1.24 | $39,928.00 | 2% 1.69M to 1.72M | |
| 25-May-22 5:58 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 20-May-22 | Private Purchase | 50,000 | $1.23 | $61,500.00 | 3% 1.64M to 1.69M | |
| 23-May-22 7:48 PM View: | Nissenson Allen Director | Elicio Therapeutics, Inc. (ELTX) | 20-May-22 | Purchase | 2,037 | $1.18 | $2,403.66 | 28% 7.35K to 9.38K | |
| 23-May-22 7:48 PM View: | Nissenson Allen Director | Elicio Therapeutics, Inc. (ELTX) | 19-May-22 | Private Purchase | 7,346 | $1.16 | $8,521.36 | 100% 0 to 7.35K | |
| 29-Dec-21 4:08 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 28-Dec-21 | Market Purchase | 210,337 | $2.66 | $559,854.00 | 15% 1.43M to 1.64M | (3%) |
| 29-Dec-21 4:08 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 27-Dec-21 | Market Purchase | 66,907 | $2.55 | $170,519.00 | 5% 1.36M to 1.43M | 2% |
| 22-Dec-21 4:06 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 20-Dec-21 | Market Purchase | 3,527 | $2.54 | $8,975.86 | < 1% 1.36M to 1.36M | 6% |
| 21-Dec-21 4:25 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 20-Dec-21 | Market Sale (Planned) | 358 | $2.62 | $938.00 | (1%) 35.49K to 35.14K | < 1% |
| 20-Dec-21 6:44 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 17-Dec-21 | Market Purchase | 13,742 | $2.54 | $34,958.30 | 1% 1.34M to 1.36M | < 1% |
| 20-Dec-21 6:44 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 16-Dec-21 | Market Purchase | 27,883 | $2.55 | $70,992.90 | 2% 1.32M to 1.34M | < 1% |
| 16-Dec-21 4:58 PM View: | Curhan Gregory S See Remarks | Elicio Therapeutics, Inc. (ELTX) | 15-Dec-21 | Market Purchase | 4,000 | $2.37 | $9,480.00 | 100% 0 to 4.0K | 5% |
| 17-Dec-21 5:13 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 15-Dec-21 | Market Purchase | 77,604 | $2.41 | $186,956.00 | 6% 1.24M to 1.32M | 7% |
| 15-Dec-21 4:06 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 14-Dec-21 | Market Sale (Planned) | 451 | $2.42 | $1,090.11 | (1%) 30.85K to 30.4K | 3% |
| 07-Dec-21 4:06 PM View: | Goldberg Itzhak See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 06-Dec-21 | Market Sale (Planned) | 32,118 | $3.35 | $107,721.00 | (2%) 1.75M to 1.72M | (2%) |
| 03-Dec-21 6:03 PM View: | Goldberg Itzhak See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 03-Dec-21 | Market Sale (Planned) | 40,215 | $3.39 | $136,216.00 | (2%) 1.79M to 1.75M | (6%) |
| 03-Dec-21 6:03 PM View: | Goldberg Itzhak See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 02-Dec-21 | Market Sale (Planned) | 38,800 | $3.51 | $136,328.00 | (2%) 1.83M to 1.79M | (2%) |
| 03-Dec-21 6:03 PM View: | Goldberg Itzhak See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 01-Dec-21 | Market Sale (Planned) | 38,867 | $3.54 | $137,667.00 | (2%) 1.87M to 1.83M | (2%) |
| 22-Nov-21 7:09 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 18-Nov-21 | Market Sale (Planned) | 374 | $4.13 | $1,544.62 | (1%) 35.87K to 35.49K | < 1% |
| 17-Nov-21 6:02 PM View: | Goldberg Itzhak See Remarks | Elicio Therapeutics, Inc. (ELTX) | 16-Nov-21 | Market Sale (Planned) | 38,495 | $4.26 | $163,808.00 | (2%) 1.91M to 1.87M | < 1% |
| 17-Nov-21 6:02 PM View: | Goldberg Itzhak See Remarks | Elicio Therapeutics, Inc. (ELTX) | 15-Nov-21 | Market Sale (Planned) | 111,505 | $4.17 | $465,243.00 | (6%) 2.02M to 1.91M | (1%) |
| 16-Nov-21 4:09 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 15-Nov-21 | Market Sale (Planned) | 433 | $4.40 | $1,905.20 | (1%) 31.28K to 30.85K | 4% |
| 20-Oct-21 5:06 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 18-Oct-21 | Market Sale (Planned) | 373 | $8.62 | $3,215.26 | (1%) 36.24K to 35.87K | (< 1%) |
| 15-Oct-21 4:10 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 14-Oct-21 | Market Sale (Planned) | 430 | $8.65 | $3,719.50 | (1%) 31.71K to 31.28K | (< 1%) |
| 21-Sep-21 10:00 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 20-Sep-21 | Market Sale (Planned) | 376 | $10.07 | $3,786.32 | (1%) 36.62K to 36.24K | (< 1%) |
| 15-Sep-21 4:31 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 14-Sep-21 | Market Sale (Planned) | 430 | $10.64 | $4,575.20 | (1%) 32.14K to 31.71K | (< 1%) |
| 31-Aug-21 7:32 PM View: | Eisa-Abc LLC 10% Owner | Elicio Therapeutics, Inc. (ELTX) | 31-Aug-21 | Disposition (other) | 913,659 | -- | -- | (25%) 3.65M to 2.74M | |
| 22-Jul-21 6:04 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 21-Jul-21 | Market Sale (Planned) | 365 | $10.98 | $4,007.70 | (< 1%) 37.36K to 37.0K | (6%) |
| 22-Jul-21 6:06 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 21-Jul-21 | Market Sale (Planned) | 432 | $10.94 | $4,726.08 | (1%) 33.02K to 32.59K | (6%) |
| 15-Jul-21 4:08 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 14-Jul-21 | Market Sale (Planned) | 431 | $11.01 | $4,745.31 | (1%) 33.02K to 32.59K | 3% |
| 17-Nov-21 6:02 PM View: | Goldberg Itzhak See Remarks | Elicio Therapeutics, Inc. (ELTX) | 24-Jun-21 | Payment of Exercise | 47,410 | $13.78 | $653,310.00 | (2%) 2.07M to 2.02M | 69% |
| 17-Dec-21 5:13 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 24-Jun-21 | Payment of Exercise | 41,091 | $13.78 | $566,234.00 | (3%) 1.28M to 1.24M | 81% |
| 21-Jun-21 4:05 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 18-Jun-21 | Market Sale (Planned) | 366 | $13.20 | $4,831.20 | (< 1%) 37.73K to 37.36K | (3%) |
| 16-Jun-21 4:06 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 14-Jun-21 | Market Sale (Planned) | 427 | $13.27 | $5,666.29 | (1%) 33.45K to 33.02K | < 1% |
| 19-May-21 5:10 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 18-May-21 | Market Sale (Planned) | 363 | $13.91 | $5,049.33 | (< 1%) 38.09K to 37.73K | (3%) |
| 18-May-21 4:04 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 14-May-21 | Market Sale (Planned) | 440 | $13.92 | $6,124.80 | (1%) 33.89K to 33.45K | < 1% |
| 20-Apr-21 5:19 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 19-Apr-21 | Market Sale (Planned) | 381 | $13.55 | $5,162.55 | (< 1%) 38.47K to 38.09K | (< 1%) |
| 15-Apr-21 4:05 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 15-Apr-21 | Market Sale | 399 | $15.01 | $5,988.99 | (1%) 34.29K to 33.89K | (< 1%) |
| 19-Mar-21 4:06 PM View: | Neylan John F. See Remarks | Elicio Therapeutics, Inc. (ELTX) | 17-Mar-21 | Market Sale | 442 | $19.13 | $8,455.46 | (1%) 38.9K to 38.45K | 5% |
| 16-Mar-21 4:11 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 13-Mar-21 | Market Sale | 499 | $20.45 | $10,204.60 | (1%) 34.78K to 34.29K | (2%) |
| 17-Feb-21 8:10 PM View: | Rhodes Jennifer J See Remarks | Elicio Therapeutics, Inc. (ELTX) | 13-Feb-21 | Market Sale | 457 | $19.54 | $8,929.78 | (1%) 35.24K to 34.78K | (2%) |
| 11-Feb-21 7:25 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Sale | 159,177 | $16.00 | $2,546,830.00 | (11%) 1.44M to 1.28M | |
| 11-Feb-21 7:22 PM View: | Ganzi Victor F Director | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Conversion | 68,863 | $11.57 | $796,745.00 | 13% 542.25K to 611.11K | |
| 11-Feb-21 7:25 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Payment of Exercise | 31,966 | $16.00 | $511,456.00 | (2%) 1.47M to 1.44M | |
| 11-Feb-21 7:25 PM View: | Venkatesan Jay See Remarks Director | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Exercise (in-the money or at-the-money) | 237,152 | $6.43 | $1,524,890.00 | 19% 1.23M to 1.47M | |
| 11-Feb-21 7:22 PM View: | Ganzi Victor F Director | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Sale | 246,720 | $16.00 | $3,947,520.00 | (25%) 978.7K to 731.98K | |
| 11-Feb-21 7:24 PM View: | Wilson Karen J Director | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Conversion | 18,718 | $11.57 | $216,567.00 | 100% 0 to 18.72K | |
| 11-Feb-21 7:23 PM View: | Omenn Gilbert S Director | Elicio Therapeutics, Inc. (ELTX) | 09-Feb-21 | Conversion | 61,657 | $11.57 | $713,372.00 | 330% 18.67K to 80.33K |
